2022
DOI: 10.5937/galmed2201022a
|View full text |Cite
|
Sign up to set email alerts
|

New oral anticoagulants in nonvalvular atrial fibrillation

Abstract: Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and its incidence is 1-2% of the world's population. Atrial fibrillation is associated with an increased risk of morbidity and mortality, primarily due to an increased risk of stroke that is five times higher than in the general population. Therefore, life-long anticoagulant therapy is indicated in patients with atrial fibrillation in the prevention of stroke when CHA2DS2-VASc [congestive heart failure, hypertension, age > 75 years,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 39 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?